Instadose Pharma Corp. (INSD)
OTC PINK OTC PINK Primary Summary
INSD Chart
Instadose Pharma Corp. (INSD) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Instadose Pharma Corp. ever had a stock split?
Instadose Pharma Corp. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Antonio Rocco Franchino CEO | OTC PINK Exchange | 45783B103 CUSIP |
| CA Country | 2 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Instadose Pharma Corp. is a pioneering company specialized in the growing, cultivation, processing, and global distribution of medical-grade cannabinoid oil. Founded in 2017, the company is headquartered in Burlington, Canada. Instadose Pharma Corp. focuses on delivering high-quality cannabinoid products, leveraging innovative cultivation and processing techniques to meet the increasing demands of the global medical markets. With a commitment to excellence and adherence to regulatory standards, Instadose Pharma Corp. is at the forefront of the medical cannabis industry, providing solutions that balance efficacy with patient safety.
Products and Services
- Medical-Grade Cannabinoid Oil
Instadose Pharma Corp. specializes in the production and distribution of medical-grade cannabinoid oil. Using advanced cultivation and processing methods, the company ensures that its cannabinoid oil meets strict quality controls and international medical standards. This product is tailored for patients seeking alternative treatments for various medical conditions, offering a pure and potent solution that emphasizes safety and efficacy.
